RecruitingNot Applicable

Mental Health and Suicidality in Glioblastoma Patients in Germany

Germany176 participantsStarted 2026-03-19

Plain-language summary

The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021) * Age ≥ 18 years Exclusion Criteria: * Participants with clinically significant aphasia or language barrier as assessed by the investigator * History of other malignant tumors * Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)

What they're measuring

Suicidality

Timeframe: in the last 4 weeks before participating in the study

Trial details

NCT IDNCT07409584

SponsorUniversity Hospital, Essen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-02-28

Contact for this trial

Christoph Oster, Dr. med.

+49201-723-82598 christoph.oster@uk-essen.de

View on ClinicalTrials.gov More Glioblastoma (GBM) trials